Last reviewed · How we verify
NCT06215300
The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.
trial testing coronary artery bypass grafting in to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting in 800 participants. Status unknown.
1 November 2025
Quick facts
| Lead sponsor | Novosibirsk Scientific Research Institute for Circulatory Pathology |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 800 |
| Start date | 1 December 2022 |
| Primary completion | 1 November 2025 |
| Estimated completion | 1 November 2025 |
| Sites | 2 locations across Russia |
Drugs / interventions tested
- coronary artery bypass grafting
Conditions studied
- to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting — all drugs for to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting →
Sponsor
Novosibirsk Scientific Research Institute for Circulatory Pathology
Who can join
Adults 18 to 90, any sex, with to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Polymorphism in the GUCY1A3 gene worsens the activity of rCC, causing vasoconstriction and increased platelet aggregation. Studies have shown the association of the GUCY1A3 gene with the risk of coronary heart disease and its complications, with ischemic stroke
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06215300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of coronary artery bypass grafting
Trials testing the same drug.
- NCT04916912 — Results of Coronary Artery Bypass Grafting in Obese Patients · completed
- NCT06749171 — Coronary Revascularization Outcomes Within Necessary Sex and Gender Aspects · completed
- NCT06614023 — Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting · completed
Other Novosibirsk Scientific Research Institute for Circulatory Pathology trials
Trials by the same sponsor.
- NCT03711136 — Comparison of stAndard and Hybrid Surgical Techniques in the Treatment of proximaL Aortic dissEctions · completed
- NCT03349164 — Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06215300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novosibirsk Scientific Research Institute for Circulatory Pathology
- Last refreshed: 22 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06215300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing